ASX
Amplia Therapeutics Limited
ATX:ASX•Healthcare
Sensitive ASX Announcement
Amplia Completes Dosing in Phase 1 Clinical Study of AMP945
Published: 15/04/21, 08:22am (AEST)•1 pages